Vericel Corporation VCEL
Super Investor & Insider
1
Fondi che lo detengono
#1369
Rank consenso
1.4%
% dei portafogli
$832,077
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Mairs & Power · Mairs & Power | 0.01% | — | 25,865 | $832,077 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Vericel Corporation is a biopharmaceutical company focused on the development and commercialization of innovative cellular therapies for patients with severe diseases and conditions. The company's primary purpose is to provide next-generation solutions that harness the power of a patient's own cells to repair damaged t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees398
TickerVCEL
Statistics
Market Cap$2.00B
Revenue (TTM)$276.3M
Net Income$16.5M
Net Margin6.0%
EPS$0.32
P/E89.70
P/S6.74
P/B5.52
EV/EBITDA68.80
ROE6.6%
Dividend Yield—
Price$39.18
Data: Twelve Data · Revenue = mcap / P/S